Post by
88guy88 on Nov 18, 2020 3:09pm
Our Study
120 people with depression tested with psilocybin strips over 4 month trial in early 2021.....Numinus study is 30 people with additions like smoking and alcohol and this study falls under compassionate study approval by Health Canada as psilocybin is still illegal in Canada....Revive has a strip application and has collaborated with PHRM (which is down 16% today on the news)..you would think it would be up but its not
a few companies starting to come to the front for trials to show benefits of psilocybin
lets hope Cybin is a winner....apprears to have a lot of instututional support and the IPO was oversubscribed with a number of quality management and advisors....will just have to see how it plays out....all cashed up 45 million and ready to rock n roll
Comment by
realitycheck00 on Nov 18, 2020 3:22pm
Good to see progress from all companies as its great for the entire industry! Leaders will deffinately evolve over time. Been holding RVV for some time as well so lets see what catalysts come out from both sides.